Redeye provides its preview ahead of Genovis’ Q3 2026 results. We expect ~28% sales growth, supported by a soft comparison base YoY and the first full quarter of KPL consolidation, while adjusted EBITDA margin is expected to remain around the levels of preceeding quarters.
LÄS MER
